Rhythm Pharmaceuticals buy Citigroup Inc.
Start price
17.03.26
/
50%
€77.50
Target price
17.03.27
€113.94
Performance (%)
23.87%
Price
07:53
?
Summary
This prediction is currently active. The prediction currently has a performance of 23.87%. This prediction currently runs until 17.03.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | -2.162% | -2.162% |
| iShares Core DAX® | 3.153% | 1.504% |
| iShares Nasdaq 100 | 7.431% | -1.584% |
| iShares Nikkei 225® | 8.571% | -4.324% |
| iShares S&P 500 | 4.578% | 1.920% |
Comments by Citigroup_Inc_ for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Citigroup Inc. from $136.00 to $131.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€96.00
05.08.26
05.08.26
€123.95
05.08.27
05.08.27
0.00%
07:53
07:53
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€93.00
27.11.25
27.11.25
€117.12
27.11.26
27.11.26
3.23%
07:53
07:53